Brennan DM - Search Results

1

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding.

Steinhubl SR, Bhatt DL, Brennan DM, Montalescot G, Hankey GJ, Eikelboom JW, Berger PB, Topol EJ; CHARISMA Investigators. Steinhubl SR, et al. Among authors: brennan dm. Ann Intern Med. 2009 Mar 17;150(6):379-86. doi: 10.7326/0003-4819-150-6-200903170-00006. Ann Intern Med. 2009. PMID: 19293071

2

Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention.

Steinhubl SR, Berger PB, Brennan DM, Topol EJ; CREDO Investigators. Steinhubl SR, et al. Among authors: brennan dm. J Am Coll Cardiol. 2006 Mar 7;47(5):939-43. doi: 10.1016/j.jacc.2005.10.047. Epub 2006 Feb 9. J Am Coll Cardiol. 2006. PMID: 16516075 Free article. Clinical Trial.

3

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ; CHARISMA Investigators. Bhatt DL, et al. Among authors: brennan dm. N Engl J Med. 2006 Apr 20;354(16):1706-17. doi: 10.1056/NEJMoa060989. Epub 2006 Mar 12. N Engl J Med. 2006. PMID: 16531616 Free article. Clinical Trial.

4

Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment.

Mukherjee D, Topol EJ, Moliterno DJ, Brennan DM, Ziada K, Cho L, Steinhubl SR; CREDO Investigators. Mukherjee D, et al. Among authors: brennan dm. Heart. 2006 Jan;92(1):49-51. doi: 10.1136/hrt.2005.064501. Epub 2005 Apr 21. Heart. 2006. PMID: 15845611 Free PMC article. Clinical Trial.

5

Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.

Saw J, Steinhubl SR, Berger PB, Kereiakes DJ, Serebruany VL, Brennan D, Topol EJ; Clopidogrel for the Reduction of Events During Observation Investigators. Saw J, et al. Circulation. 2003 Aug 26;108(8):921-4. doi: 10.1161/01.CIR.0000088780.57432.43. Epub 2003 Aug 18. Circulation. 2003. PMID: 12925453 Clinical Trial.

6

Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention.

Saw J, Topol EJ, Steinhubl SR, Brennan D, Berger PB, Moliterno DJ; CREDO Investigators. Saw J, et al. Am J Cardiol. 2004 Sep 1;94(5):623-5. doi: 10.1016/j.amjcard.2004.05.026. Am J Cardiol. 2004. PMID: 15342293

7

Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.

Tang WH, Steinhubl SR, Van Lente F, Brennan D, McErlean E, Maroo A, Francis GS, Topol EJ. Tang WH, et al. Am Heart J. 2007 Jan;153(1):36-41. doi: 10.1016/j.ahj.2006.10.011. Am Heart J. 2007. PMID: 17174634

8

Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial.

Hankey GJ, Johnston SC, Easton JD, Hacke W, Mas JL, Brennan D, Mak KH, Bhatt DL, Fox KA, Topol EJ; CHARISMA trial investigators. Hankey GJ, et al. Int J Stroke. 2011 Feb;6(1):3-9. doi: 10.1111/j.1747-4949.2010.00535.x. Int J Stroke. 2011. PMID: 21205234 Clinical Trial.

9

Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials.

Roffi M, Mukherjee D, Chew DP, Bhatt DL, Cho L, Robbins MA, Ziada KM, Brennan DM, Ellis SG, Topol EJ. Roffi M, et al. Among authors: brennan dm. Circulation. 2002 Dec 10;106(24):3063-7. doi: 10.1161/01.cir.0000041250.89627.a9. Circulation. 2002. PMID: 12473552

10

Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial.

Brener SJ, Steinhubl SR, Berger PB, Brennan DM, Topol EJ; CREDO Investigators. Brener SJ, et al. Among authors: brennan dm. J Invasive Cardiol. 2007 Jul;19(7):287-90. J Invasive Cardiol. 2007. PMID: 17620671 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page